View |
|
DRP-7920-03
|
Levofloxacin (as Hemihydrate)
|
Levoxid
|
5 mg/mL (500 mg/100 mL)
|
Solution for I.V. Infusion
|
ANTIBACTERIAL (FLUOROQUINOLONE)
|
Eurolife Healthcare Pvt.Ltd.
|
India
|
-
|
29 March 2022
|
25 July 2026
|
View |
|
DRP-8586-11
|
Trimetazidine dihydrochloride
|
Unbranded
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
21 March 2024
|
18 December 2029
|
View |
|
DRP-8832-02
|
Ceftriaxone (As Sodium)
|
Aetricef-W
|
1 g
|
Powder For Injection (IM/IV)
|
ANTIBACTERIAL (THIRD-GENERATION CEPHALOSPORIN)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
-
|
29 March 2022
|
10 November 2025
|
View |
|
DRP-8901-03
|
Sitagliptin (as phosphate)
|
Astaliptin
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
-
|
29 March 2022
|
08 June 2025
|
View |
|
DRP-8929-09
|
Norepinephrine (as bitartrate)
|
Norecent
|
1 mg/mL (4 mg/4mL)
|
Solution for Injection (I.V.)
|
Adrenergic/Dopaminergic Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
-
|
29 March 2022
|
29 June 2025
|
View |
|
DRP-9232-03
|
Levetiracetam
|
Lepixa
|
100 mg/mL (500 mg/5mL)
|
Solution for Injection (IV)
|
Antiepileptic
|
Aspiro Pharma Limited
|
India
|
-
|
29 March 2022
|
09 November 2025
|
View |
|
DRP-9317-02
|
Esomeprazole (as Magnesium Dihydrate)
|
Eso-eve
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Acme Formulation Pvt. Ltd.
|
India
|
-
|
29 March 2022
|
25 November 2025
|
View |
|
DRP-10424-02
|
Telmisartan
|
Emzart 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
-
|
29 March 2022
|
25 October 2026
|
View |
|
DRP-10530-01
|
Linezolid
|
Zoligen
|
2 mg/mL (600 mg/300 mL)
|
Solution for Injection for IV Infusion
|
Antibacterial (Oxazolidinone)
|
Ahlcon Parenterals (India) Limited
|
India
|
-
|
29 March 2022
|
12 October 2026
|
View |
|
DRP-10623-03
|
Sitagliptin (as phosphate)
|
Acantha
|
100 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
-
|
29 March 2022
|
28 October 2026
|
View |
|
DRP-10890-01
|
Cefepime (as hydrochloride) + Sulbactam (as sodium)
|
Carpime
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor
|
Swiss Parenterals Ltd
|
India
|
-
|
29 March 2022
|
14 December 2026
|
View |
|
DRP-11080-01
|
Ceftriaxone (as Sodium) + Sulbactam (as Sodium)
|
Tritam
|
1 g/500 mg
|
Powder for Injection (I.M./I.V)
|
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor
|
Reyoung Pharmaceutical Co. Ltd
|
China
|
-
|
29 March 2022
|
26 January 2027
|
View |
|
DRP-6433-01
|
Levetiracetam
|
Lepixa 1000
|
1 g
|
Film-Coated Tablet
|
Antiepileptic
|
Hetero Labs Limited (Unit III)
|
India
|
-
|
29 March 2022
|
22 November 2025
|
View |
|
DRP-11544
|
Ascorbic acid + Citrus Bioflavonoids + Rosa canina L. (Rose hips) Fruit + Zinc
|
BRTJ Formula Finest Choice C Plus
|
1 g/50 mg/10 mg/5.5 mg
|
Tablet
|
-
|
Vecta Biotech
|
India
|
-
|
28 March 2022
|
13 August 2025
|
View |
|
DRP-11543
|
Hydrocortisone (As Acetate)
|
Kurt
|
10 mg/g (1% w/w)
|
Topical Cream
|
-
|
S Kant Healthcare Limited
|
India
|
-
|
28 March 2022
|
05 August 2026
|
View |
|
DRP-6432-02
|
Levetiracetam
|
Lepixa 500
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Hetero Labs Limited
|
India
|
Renewal
|
09 January 2023
|
30 November 2027
|
View |
|
DRP-8900-03
|
Sitagliptin (as phosphate)
|
Astaliptin
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
-
|
24 March 2022
|
08 June 2025
|
View |
|
DRP-9172-01
|
Telmisartan + Amlodipine (Besilate)
|
Tel-Amlo 80
|
80 mg/5 mg
|
Tablet
|
ANGIOTENSIN II RECEPTOR BLOCKER/ CALCIUM CHANNEL BLOCKER
|
Genuone Sciences Inc.
|
Korea
|
-
|
24 March 2022
|
25 September 2025
|
View |
|
DRP-9648-01
|
Paracetamol
|
Parachem-250
|
250 mg/ 5mL
|
Suspension (Tutti - Fruti Flavor)
|
Analgesic/Antipyretic
|
Mascot Health Series Pvt. Ltd
|
India
|
-
|
24 March 2022
|
20 April 2026
|
View |
|
DRP-9650-01
|
Paracetamol
|
Parachem-100
|
100mg/mL
|
Suspension (Oral Drops) (Tutti Fruti Flavor)
|
Analgesic/Antipyretic
|
Mascot Health Series Pvt. Ltd.
|
India
|
-
|
24 March 2022
|
20 April 2026
|